SES · BSL.SI
Raffles Medical Group Ltd
SGD 0.82+SGD 0.01 (+0.61%)
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
Loading market information…
SES · H02.SI · SGD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:09 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
Haw Par Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 29.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Haw Par Corporation Limited’s forward annual dividend is SGD 0.40 per share, paid semi-annual. The forward yield is 3.09% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Haw Par Corporation Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Singapore in 1969, Haw Par Corporation Limited specializes in the manufacturing, marketing, and global trade of healthcare products, serving markets in Singapore, ASEAN countries, other Asian regions, and beyond. The company's business activities are structured into three main segments: Healthcare, Investments, and Others. Its Healthcare segment primarily produces and distributes topical pain relief solutions, prominently featuring the Tiger Balm and Kwan Loong brands. The Investments segment focuses on acquiring publicly traded securities. The corporation also offers family and tourist-oriented leisure experiences, notably through oceanariums. Furthermore, it provides leasing services for land, buildings, and office spaces, in addition to offering management support.
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SGD 0.82+SGD 0.01 (+0.61%)
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
SGD 0.05+SGD 0.00 (+2.13%)
Thomson Medical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.36% below the high.
SGD 0.74-SGD 0.01 (-0.68%)
Riverstone Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 25.38% below the high.
$9.58-$0.70 (-6.81%)
Adlai Nortye Ltd.’s quoted price sits in the upper half of its reported 52-week range, 44.29% below the high.
$0.46-$0.02 (-3.16%)
UltraGreen.ai Limited’s quoted price sits in the lower half of its reported 52-week range, 75.27% below the high.
SGD 0.51+SGD 0.01 (+2.0%)
iX Biopharma Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.4% below the high.
SGD 0.49SGD 0.00 (0.0%)
Q & M Dental Group (Singapore) Limited’s quoted price sits in the lower half of its reported 52-week range, 22.83% below the high.
₩4,020-₩135 (-3.25%)
Prestige BioPharma Limited’s quoted price sits in the lower half of its reported 52-week range, 71.53% below the high.
